Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T11997 |
MELK-IN-1
Nintedanib Impurity L,MELK inhibitor 17,尼达尼布杂质L |
MELK | PI3K/Akt/mTOR signaling |
MELK-IN-1 (MELK inhibitor 17)是一种母体胚胎亮氨酸拉链激酶的有效抑制剂,IC50=3 nM,Ki=0.39 nM。 | |||
T11996 |
MELK-8a hydrochloride
|
MELK | PI3K/Akt/mTOR signaling |
MELK-8a hydrochloride 是一种有效的母体胚胎亮氨酸拉链激酶抑制剂,IC50 为 2 nM。 | |||
T1759 |
OTSSP167
MELK inhibitor,OTS167 |
MELK | PI3K/Akt/mTOR signaling |
OTSSP167 (OTS167) 是一种高效的,ATP 竞争性的 MELK 抑制剂,其 IC50=0.41 nM。 | |||
T35342 | MELK-8a Dihydrochloride | MELK | PI3K/Akt/mTOR signaling |
MELK-8a Dihydrochloride 是一种新型的母体胚胎亮氨酸拉链激酶(MELK)抑制剂,其 IC50值为2 nM。 | |||
T11725 |
JNJ-47117096 hydrochloride
MELK-T1 hydrochloride |
Others | Others |
JNJ-47117096 hydrochloride is potent and selective MELK inhibitor, with an IC50 of 23 nM, also effectively inhibits Flt3, with an IC50 of 18 nM. | |||
T62417 |
MELK-8a
|
||
MELK-8a (NVS-MELK8a) 是一种高效的、选择性的母体胚胎亮氨酸拉链激酶 (MELK) 抑制剂 (IC50: 2 nM)。MELK-8a 也能够抑制 Flt3 (ITD) (IC50: 0.18 μM)、Haspin (IC50: 0.19 μM)、PDGFRα (IC50: 0.42 μM)。其中 MELK 在调节癌细胞的细胞有丝分裂中具有重要作用。 | |||
T21559 |
OTSSP167 hydrochloride
OTSSP 167 盐酸盐 |
MELK | PI3K/Akt/mTOR signaling |
OTSSP167 hydrochloride 是一种高效的,ATP 竞争性的MELK 抑制剂,其 IC50=0.41 nM。 | |||
T4327 |
Prexasertib dihydrochloride
LY2606368 (dihydrochloride),Prexasertib HCl,LY2606368 |
Apoptosis; Chk; S6 Kinase | Apoptosis; Cell Cycle/Checkpoint; MAPK; PI3K/Akt/mTOR signaling |
Prexasertib dihydrochloride (LY2606368) 是一种选择性的,ATP 竞争性的细胞周期检测点激酶 1 抑制剂,Ki 为 0.9 nM,IC50为 <1 nM。它抑制 CHK2(IC50=8 nM) 和 RSK1 (IC50=9 nM)。它引起双链 DNA 断裂和复制突变,导致细胞凋亡,有抗肿瘤活性。 | |||
T4310 |
Prexasertib
5-[[5-[2-(3-氨基丙氧基)-6-甲氧基苯基]-1H-吡唑-3-基]氨基]-2-吡嗪甲腈,LY2606368 |
Apoptosis; Chk | Apoptosis; Cell Cycle/Checkpoint |
Prexasertib (LY2606368) 是一种具有潜在抗肿瘤活性的检查点激酶 1 抑制剂。它可引起双链 DNA 断裂和复制突变,导致细胞凋亡。 | |||
T24152 |
HTH-01-091
HTH-01091,HTH01-091,HTH 01-091,HTH 01091 |
Serine/threonin kinase; Pim; MELK; DYRK; CDK; RIP kinase | Apoptosis; Cell Cycle/Checkpoint; Chromatin/Epigenetic; JAK/STAT signaling; Metabolism; NF-κB; PI3K/Akt/mTOR signaling; Tyrosine Kinase/Adaptors |
HTH-01-091 是一种强效且选择性的 maternal embryonic leucine zipper kinase (MELK) 抑制剂(IC50 :10.5 nM)。HTH-01-091 对PIM1/2/3、RIPK2、DYRK3、smMLCK 和 CLK2有抑制作用。HTH-01-091 可用于研究乳腺癌。 | |||
T71197 | JW-7-25-1 | ||
JW-7-25-1 is a potent multi-target inhibitor, acting on MELK, PIK3CA, mTOR, GSK3A and CDK7. | |||
T79582 |
Antitumor agent-116
|
MELK | PI3K/Akt/mTOR signaling |
Antitumor agent-116 (compound 6C) 是一种显示出对MELK受体具有结合亲和力的抗肿瘤剂,它具有抗增殖活性并能诱导细胞凋亡(apoptosis)。 | |||
T73867 | HTH-01-091 TFA | ||
HTH-01-091 TFA 是一种强效且选择性的maternal embryonic leucine zipper kinase (MELK)抑制剂,其IC50为 10.5 nM。HTH-01-091 TFA 还能抑制PIM1/2/3、RIPK2、DYRK3、smMLCK 和CLK2。HTH-01-091 TFA 可用于乳腺癌研究。 | |||
T12237 |
NMS-P715
|
Casein Kinase; Kinesin; MELK; MAPK | Cytoskeletal Signaling; MAPK; Metabolism; PI3K/Akt/mTOR signaling; Stem Cells |
NMS-P715 是一种 ATP 竞争性MPS1选择性抑制剂,IC50值为 182 nM。 | |||
T82385 |
FMF-06-098-1
|
PROTACs | PROTAC |
FMF-06-098-1是一种多靶点蛋白降解剂。通过专一性降解作用,FMF-06-098-1针对多种激酶,能够有效降解AAK1, ABL2, AURKA, AURKB, BUB1B, CDC7, CDK1, CDK12, CDK13, CDK2, CDK4, CDK6, CDK7, CDK9, CHEK1, CSNK1D, EPHA1, PER, FGFR1, GAK, IRAK4, ITK, LIMK2, MAP4K2, MAP4K3, MAPK6, MAPK7, MARK4, MELK, PKN3, PLK4, PRKAA1, PTK2, PTK6, RPS6KA4, S1K2, STK35, TNK2, UHMK1, ULK1及WEE1等关键蛋白。 | |||
T16142 |
MRT199665
|
Others | Others |
MRT199665 is an effective and ATP-competitive, selective MARK/SIK/AMPK inhibitor (IC50s of 2/2/3/2 nM, 10/10 nM, and 110/12/43 nM for MARK1/MARK2/MARK3/MARK14, AMPKα1/AMPKα2, and SIK1/SIK2/SIK3, respectively). MRT199665 suppresses the phosphorylation of S |